Filter
6512
Filtered Results: 6512
Text search:
drug
use
Featured
Recommendations
569
New Publications
1627
Language
Document type
No document type
3813
Studies & Reports
1010
Guidelines
851
Manuals
298
Strategic & Response Plan
192
Fact sheets
140
Training Material
95
Infographics
30
Situation Updates
28
Resource Platforms
21
Brochures
18
Online Courses
10
App
3
Videos
2
Dashboards/Maps
1
Countries / Regions
India
386
Global
218
Kenya
187
South Africa
158
Western and Central Europe
139
Ethiopia
138
Uganda
134
Nigeria
122
Nepal
114
Tanzania
111
Sierra Leone
98
Liberia
95
Malawi
94
Zambia
93
Africa
91
Latin America and the Carribbean
86
Myanmar / Burma
86
Bangladesh
81
Ghana
79
Ukraine
74
Eastern Europe
72
Rwanda
70
Namibia
65
Philippines
55
Russia
55
Zimbabwe
48
Asia
47
South–East Asia Region
42
Cambodia
40
Lesotho
38
Indonesia
37
Congo, Democratic Republic of
31
Brazil
31
Mozambique
30
Botswana
30
Syria
29
Senegal
26
Eswatini/ Swaziland
25
Germany
23
East and Southern Africa
23
Burkina Faso
21
Colombia
20
West and Central Africa
19
Middle East and North Africa
19
South Sudan
18
Cameroon
17
Haiti
17
Eastern Europe and Central Asia
17
USA
16
Tajikistan
15
Venezuela
15
Albania
14
Vietnam
14
Thailand
12
Guinea
12
Pakistan
12
China
11
Georgia
11
Afghanistan
10
Peru
10
Argentina
10
Moldova
10
Benin
9
Paraguay
9
Sudan
9
Laos
8
Armenia
8
Chile
7
Sri Lanka
7
Yemen
7
North Macedonia
6
Mexico
6
El Salvador
6
Western Pacific Region
6
North America
6
Bolivia
6
Mali
6
Jordan
5
Spain
5
Lebanon
5
Central African Republic
5
Iraq
5
Somalia
5
Ecuador
5
Switzerland
4
Timor Leste/ East Timor
4
Turkey
4
Iran
4
Estonia
4
Jamaica
4
United Kingdom
4
Papua New Guinea
4
Angola
4
Libya
4
Bhutan
4
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Guinea-Bissau
3
Uruguay
3
Belarus
3
Palestine
3
Honduras
3
Madagascar
3
Serbia
2
Kazakhstan
2
Canada
2
Morocco
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Tunisia
2
Portugal
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Nicaragua
2
Romania
2
Poland
2
Chad
2
Guatemala
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Austria
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Lithuania
1
Ireland
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Greece
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2454
Clinical Guidelines
559
Public Health
292
Women & Child Health
234
Key Resources
172
Capacity Building
105
Pharmacy & Technologies
77
Annual Report MEDBOX
1
Toolboxes
HIV
767
Mental Health
693
TB
622
AMR
322
COVID-19
313
NTDs
270
Pharmacy
206
NCDs
154
Caregiver
125
Malaria
117
Ebola & Marburg
98
Refugee
86
Planetary Health
78
Rapid Response
76
Disability
70
Conflict
67
Global Health Education
57
Health Financing Toolbox
52
2.0 Rapid Response
29
Cholera
25
Polio
25
Natural Hazards
23
Specific Hazards
22
Zika
22
Social Ethics
19
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
Teachers' Exercise Book for HIV Prevention
Document 6.1
This booklet contains all the participatory learning experiences that are included in the Training and Resource Manual on School Health and HIV and AIDS Prevention. It is to be given to all teachers who receive training as part of the EI/WH...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
This guideline provides health policy-makers and decision-makers in health professional training institutions with advice on the rationale for health-care providers’ use of counselling skills to address sexual health concerns in a primary health care setting
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
WHO Recommended Surveillance Standards
recommended
Second editon. This document serves only as a guide to good practice and may help to harmonize surveillance activities. The purpose of this manual is to be a handy reference for key elements and contact information for all communicable diseases / syndromes associated with current WHO control program...
This manual is designed to provide comprehensive malaria case management training for health workers at all levels, including clinical, nursing, dispensing, laboratory and records staff. The training covers the use of malaria rapid diagnostic tests (RDTs) and the treatment of severe malaria. The fiv...
Policy Brief. Good practice statement: When planning and implementing a response for HIV, viral hepatitis and sexually transmitted diseases (STIs), policy-makers and providers should be aware that
counselling behavioural interventions aimed to change behaviours to reduce risks associated
with th...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
